Natus Medical Incorporated BABY has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because BABY is now in overbought territory with an RSI value of 76.71.
What is RSI?
RSI stands for ‘Relative Strength Index’ and it is a popular indicator used by technically focused investors. It compares the average of gains in days that closed up to the average of losses in days that closed down; readings above 70 suggest an asset is overbought, while an RSI below 30 suggests undervalued conditions are present.
Yet BABY’s high RSI value isn’t the only reason for investors to be concerned, as there has been some decidedly negative earnings estimate revisions in Natus Medical’s stock as of late. This is especially true when investors dive into some of these revisions in order to get a better picture of BABY’s prospects for the near term.
Over the past two months, investors have witnessed 1 earnings estimate revision lower compared to none higher for the current year. The consensus estimate for BABY has also been on a downward trend over the same time period too, as the estimate has fallen from $1.85/share two months ago to just $1.63/share today.
If this wasn’t enough, Natus Medical also has a Zacks Rank #5 (Strong Sell)which puts it into unfortunate company among its peers. So, given all of these factors, investors may want to consider exiting this stock now before it falls back to Earth.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Zacks Editor-in-Chief Goes ""All In"" on This Stock
Full disclosure, Kevin Matras now has more of his own money in one particular stock than in any other. He believes in its short-term profit potential and also in its prospects to more than double by 2019. Today he reveals and explains his surprising move in a new Special Report.
Download it free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Natus Medical Incorporated (BABY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research